Martayan A, Fiscella M, Setini A, Ciccarelli G, Gambari R, Feriotto G, Beretta A, Siccardi A G, Appella E, Giacomini P
Immunology Laboratory, Regina Elena Institute CRS, Rome, Italy.
Hum Immunol. 1997 Mar;53(1):23-33. doi: 10.1016/S0198-8859(96)00256-X.
A beta 2-microglobulin (beta 2m)-deficient kidney carcinoma cell line and three monoclonal antibodies to the alpha 1 (L31), alpha 2 (W6/32), and alpha 3 (Q1/28) domain of class I HLA molecules were selected to assess the role of beta 2m in regulating the conformation and surface expression of HLA-C molecules. HLA-A2, -B27, and -CW1 molecules synthesized by beta 2m-deficient cells were compared to heavy chains synthesized in transfectants expressing a large excess of beta 2m. As assessed by differential binding with monoclonal antibodies and partitioning studies in the detergent TX-114, no HLA-A2, -B27, or -CW1 molecules can be expressed, in a correct conformation, by beta 2m-deficient cells. These cells, however, do express low but significant amounts of free HLA-CW1 heavy chains at the cell surface. Transfection with beta 2m causes a coordinate change in the antibody reactivity of the three domains of HLA-CW1 molecules, thereby providing the first experimental demonstration that assembly with beta 2m affects the folding of not only the alpha 1 and alpha 2, but also of the alpha 3 domain. HLA-CW1 heavy chains, when free of beta 2m, are less soluble in the detergent TX-114 than free HLA-B27 heavy chains, and when associated with beta 2m share an alpha 3 domain epitope with free HLA-A2 and -B27 heavy chains. Moreover, their assembly with beta 2m is largely incomplete. Those data additionally demonstrate an impaired ability of HLA-CW1 to properly fold and establish a close similarity of HLA-CW1 to murine Db and Ld molecules. Although the functional role, if any, of free HLA-CW1 heavy chains remains to be determined, the present study demonstrates that the absence of beta 2m does not completely ablate class I expression in neoplastic cells of human origin.
选择一种β2-微球蛋白(β2m)缺陷的肾癌细胞系以及三种针对I类HLA分子α1(L31)、α2(W6/32)和α3(Q1/28)结构域的单克隆抗体,以评估β2m在调节HLA-C分子构象和表面表达中的作用。将β2m缺陷细胞合成的HLA-A2、-B27和-CW1分子与在表达大量β2m的转染子中合成的重链进行比较。通过与单克隆抗体的差异结合以及在去污剂TX-114中的分配研究评估,β2m缺陷细胞无法以正确的构象表达HLA-A2、-B27或-CW1分子。然而,这些细胞确实在细胞表面表达少量但显著量的游离HLA-CW1重链。用β2m转染会导致HLA-CW1分子三个结构域的抗体反应性发生协同变化,从而首次通过实验证明与β2m组装不仅影响α1和α2结构域的折叠,还影响α3结构域的折叠。游离的HLA-CW1重链在去污剂TX-114中的溶解度低于游离的HLA-B27重链,并且与β2m结合时与游离的HLA-A2和-B27重链共享一个α3结构域表位。此外,它们与β2m的组装在很大程度上是不完全的。这些数据还证明了HLA-CW1正确折叠的能力受损,并显示出HLA-CW1与小鼠Db和Ld分子有密切的相似性。尽管游离的HLA-CW1重链的功能作用(如果有的话)仍有待确定,但本研究表明β2m的缺失并未完全消除人源肿瘤细胞中的I类表达。